Tci Wealth Advisors, Inc. Vericel Corp Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$22.62 - $32.54 $3,053 - $4,392	135 New	135 $3,000
Q2 2022 Jul 19, 2022	SELL	$22.88 - $39.45 $5,605 - $9,665	-245 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$31.69 - $43.29 $7,764 - $10,606	245 New	245 $9,000
Q4 2021 Jan 24, 2022	SELL	$35.2 - $52.6 $5,596 - $8,363	-159 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$47.2 - $67.81 $4,531 - $6,509	96 Added 152.38%	159 $8,000
Q1 2021 Apr 29, 2021	BUY	$30.93 - $59.48 $1,948 - $3,747	63 New	63 $3,000

276

48.4M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.76B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.